ISSN: 2641-1687
Ali Bourgi*1, Sleiman Merhej2, Flavio Ordones3 and Elias Ayoub4
Received: February 08, 2021; Published: February 18, 2021
Corresponding author: Ali Bourgi, Hopital Français du Levant, Lebanon
DOI: 10.32474/JUNS.2021.03.000155
A lymphocele is a common finding after renal transplantation. The majority of patients are asymptomatic. However, once a lymphocele has become symptomatic, this condition has to be treated. Lymphoceles may originate either from the lymphatic system of the recipient or the transplanted kidney. The most sensible measures to prevent their occurrence therefore seems to be to restrict the transplant bed to the smallest permissible level with careful ligature of the lymphatic vessels in the area of the kidney hilum.
Therapy of a lymphocele after renal transplantation should commence with minimally invasive measures and continue with invasive procedures only if these are unsuccessful, namely, puncture and drainage then sclerotization, and then laparoscopic or open marsupialization.
Keywords: Lymohocele; kidney; transplantation; recipient
Lymphocele is a well-known complication of renal
transplantation occurring in 0,6% to 22% of the recipients [1-
4]. Lymphocele may require surgical intervention because of the
complications they cause urinary obstruction, leg edema, deep
vein thrombosis, pelvic discomfort, herniation, and lymph leakage
through the wound [5]. There are many contributing factors to
lymphocele occurrence after kidney transplantation. One of these
is donor renal lymphatics. It has been proposed that meticulous
ligation of severed lymphatics of the kidney graft in the back table
especially in the laparoscopically procured kidneys may decrease
the lymphatic complications after transplantation [6].
Although various methods of diagnosis, management, and
prevention have been discussed in the literature, the primary focus
has been on treatment and no review has summarized all issues
together. The aim of this study was to summarize the current
strategies for the prevention and management of lymphoceles.
The development of lymphoceles after renal transplantation
is well documented. The etiology of lymphoceles remains unclear,
although they are present in all kidney transplant experiences [7].
The old controversy whether lymphocele is the result of lymph
leakage from either the severed recipient iliac lymphatic vessels or
the grafted kidney lymphatics seems to favor the latter [8].
A physiological review shows that lymphatic capillaries are
more abundant in the kidney cortex compared to the medulla. They
run along the intralobular, arcuate and interlobar arteries; not only
beside theses arteries but also within their walls [9]. At the renal hilum, 2 to 5 lymphatic ducts are found in close proximity to the
main vessels (renal artery and vein).
The well-known and commonly cited contributing factors for
lymphocele formation include: the type of immunosuppression
used [10], high dose steroid use, use of diuretics, extensive
perivascular dissection of the iliac vessels, acute rejection episodes,
delayed graft function, source of graft (cadaveric vs living related
donor), the etiology of the patient’s renal failure such as adult
polycystic kidney disease, re transplantation, and some pediatric
population [2, 7, 11].
Concerning the pediatric population, in a retrospective single
institution review of 241 pediatric kidney transplants performed
from 2000 to 2013; Giuliani et al. showed that older age (≥11
yr), male gender, BMI percentile for age ≥95%, and multiple
transplantations were Significant risk factors for lymphocele
formation [12].
The formation of post-transplant lymphoceles obviously
originates in the surgical transection of lymphatic ducts. As
demonstrated by lymphangiography two sources of lymphatic leak
have been proposed: injured lymphatics in recipient’s iliac space
and injured lymphatics in the kidney graft [13,14].
A possible distinction between these two origins is feasible by
analyzing their composition. In fact, reports showed higher levels
of creatine kinase in lower limbs lymphatics vessels compared to
renal lymphatics [15-17].
It was believed that the perivascular lymphatics dissection
along the iliac vessels was a determining factor for lymphocele
development, and that lymphocele could be prevented by ligation of
these vessels. Despite many reports showing absence of lymphocele
after an accurate ligation of the iliac lymphatics [18], things are still
unclear.
Many studies were published concerning the influence of some
surgical aspects in decreasing the lymphocele incidence. Indeed,
one prospective study suggested a cephalad implantation of the
renal graft using vascular anastomoses on the common iliac vessels
to minimize lymphocele incidence, but this technique has not yet
gained wide exposure [11].
The same concept was reevaluated in another study. This time,
a significant reduction of the incidence of lymphocele from 8.5% to
2.1% was noted in 140 patients operated with the new technique
versus 140 patients in the control group operated with the standard
method [14].
Another retrospective study done by Saidi et al, evaluated the
impact of laparoscopic living donor nephrectomy on lymphatic
complications after kidney transplantation. They concluded that
the incidence of prolonged lymphatic leak is higher in recipients
who received kidney grafts procured laparoscopically. These
observations may indicate that the major source of persistent
lymphatic leakage is lymphatics of the allograft rather than
severed recipient lymphatics. More meticulous ligation of severed
lymphatics of the kidney graft in the back table, especially in the
laparoscopically procured kidneys, may decrease the lymphatic
complications after kidney transplantation [13].
To our date, many researchers are still questioning whether
surgical preparation of the kidney with accurate ligature of the hilar
lymphatic vessels would effectively reduce its incidence. Hence, a
clear answer is reported in our study favoring lymphatic vessels
ligation over non preparation of the kidney graft on lymphocele
incidence. Indeed, acute rejection rates dropped significantly from
15 to 6.3%, and incidence of symptomatic lymphocele decreased
from 17.5% to 0%.
Ultrasound is currently the preferred method for diagnosis
of lymphoceles after the renal transplantation. In complicated
cases, radioisotope imaging, computed tomography and magnetic
resonance imaging are additional methodologies commonly
used[5].
Lymphoceles may lead to deterioration of renal function and
the patient with a lymphocele may be inappropriately treated
for allograft rejection. Other clinical findings associated with
lymphoceles in renal allograft recipients include lower abdominal
swelling or mass, edema over the allograft or of the ipsilateral
leg, hypertension, drainage from the incision, enlarged allograft,
fever without an obvious source of infections, urinary frequency,
ipsilateral ileo femoral thrombo phlebitis, and weight gain [4].
Prevention of lymphocele formation primarily involves the
best method for controlling perivascular lymphatic leaks. A study
comparing surgical ties to ultrasonic devices in the surgical
dissection technique for control of lymphatics failed to show
a statistical advantage to either technique when groups were
compared based on patient age, gender, graft source, or repeat
transplant [19].
Berardinelli et al. demonstrated the effectiveness of a synthetic
polyethylenglycol(PEG) sealant to prevent lymphocele formation
after kidney transplantation [20].
Lymphoceles are usually asymptomatic and diagnosed incidentally by ultrasound. In most cases, lymphocele disappear spontaneously without any need for a treatment. Several important factors can guide our choice of treatment: severity of the symptoms, lesion size, potential post-therapeutic complications, and the clinical condition of the patient. For the conservative treatment of posttransplant lymphoceles, percutaneous needle aspiration, continuous drainage over a period of time via various kinds of catheters, and sclerotherapy with various agents have been proposed [21].
Ultrasound-guided aspiration can be used as a diagnostic tool or treatment. to both diagnose and treat a lymphocele. It can be used as the initial treatment modality to relieve urinary obstruction, recover kidney function, and prevent emergency situations. Although simple, safe, and economical, a repeated treatment may be necessary with a low a low risk of infection in each aspiration. A systematic review by Lucewicz et al. [4] looking at over 20 studies, reported that simple aspiration alone has a recurrence rate ranging between 10% and 95% [ 22].
A lymphocele can also be treated by external drainage by placing a drain. However, this procedure takes a long time and can cause problems related to major fluid loss and secondary infection (particularly in immunosuppressed transplant recipients). External drainage has an efficacy of 50% and a recurrence rate of 20%–60% [23].
The instillation of a sclerosing agent is another treatment
approach.
These include povidone iodine, fibrin glue, 95% ethanol,
fibrinogen, bovine protease inhibitor, human thrombin, calcium
chloride, gentamy sodium tetradecyl sulphate and tetracycline].
The sclerosing agent has been instilled and kept in situ for varying
periods ranging from 5 min to 24 h [24,25].
Tasar et al., reported a mean therapy duration of 17 days and a
mean alcohol volume of 30 cm3 per session. Out of 18 cases, there
was one recurrence, one graft loss, and ten minor complications
including local discomfort and low- grade fever. The authors
concluded that this method of sclerotherapy was safe and costeffective
[25].
Another analysis of 30 lymphocele patients demonstrated that
alcohol injection was a safe and cost-effective treatment, with a
success rate of 94%. The authors reported two cases of recurrence
and all complications were minor, including catheter-induced
infections and catheter displacements [26]. Povidone iodine has
been used also as a sclerotherapy agent with a failure rate of less
than11%, but it takes 20–30 days for leaking to cease and iodineinduced
acute kidney failure may occur [27]. Limited success has
been reported using tetracycline as a sclerosing agent [28].
Instillation of sclerosing agents improves the rate of success
of percutaneous management; however, it may cause a dense scar
around the renal transplant with potential problems in the longterm
[21].
Continuous drainage as well as repeated instilling of sclerosants
could be done if needed, by placing a percutaneous drain. However,
the main problem encountered during repeated installation of
sclerosants is the risk of introducing infection. Furthermore,
several case reports have reported direct graft injury and graft loss
as a result of sclerosant installation [25]. Hence, with the cost of
repetition, it is worthwhile emphasizing that external drainage or
sclerosing therapy are not correct options.
Post-transplant lymphoceles have also been treated with
a combination of percutaneous aspiration and sclerotherapy.
Although this reduced the recurrence rate, recurrences were still
reported in 20% of cases [22].
-Surgery: Byron et al. [29] first described open surgical internal
drainage in 1966, and these techniques have successfully been used
in many patients; however, they still reflect an invasive procedure.
The operative strategy is to perform a peritoneal fenestration
through a laparotomy, minilaparotomy, or via a laparoscopic
approach. Some authors suggest the use of an omentum flap to
decrease the risk of lymphocele relapse, but others do not [30].
Open surgical drainage of lymphocele is required in the
presence of infection (external drainage) or where laparoscopic
fenestration is not possible (internal drainage to the peritoneum).
The open procedure is safe and 100% effective because the
lymphocele can be localized accurately. However, the recurrence
rate is still 15%. This may be attributed to the high rate of lymph
vessel injuries incurred during the open method.
The recurrence rate of the laparoscopic method is lower (0%–
10%) because the rate of lymph vessel injuries is lower. Also, the
hospitalization period is shorter in this method [31].
In a meta-analysis, Lucewicz et al reported that 12% of
laparoscopic operations had to be converted to open surgery,
due to technical difficulty in reaching the lymphocele, peritoneal
adhesions, thick, impenetrable lymphocele capsule and injury
to abdominal viscus [21]. Indeed, it would be helpful in some
cases to use an intra-operative ultrasound can avoid organ injury
during laparoscopy. Schips et al reported a technique by which the
lymphocele was laparoscopically fenestrated under diaphanoscopic
guidance and the lymphocele cavity was dilated through the
injection of a sterile fluid. Using this approach, the authors were
able to determine the exact site of the incision by detecting the light
of the cystoscope [32].
Laparoscopic fenestration can cause intestinal herniation into the peritoneal window leading sometimes to strangulation requiring urgent intervention. However, in this era of laparoscopy, open drainage is only of historical importance. in addition, the effectiveness of the laparoscopic approach along with its, low recurrence rate, and low complication rate make it the treatment of choice when other methods fail [28].
Lymphoceles are common and well-known complications that occur in up to 26% of kidney transplant recipients. The cause of lymphocele formation is unclear, but it is believed to result from transection of the lymphatic vessels accompanying the external iliac vessels during transplantation surgery and subsequent lymph accumulation in a nonepithelialized cavity in the extra-peritoneal plane adjacent to the transplanted kidney. In order to prevent the formation of a lymphocele, preparative steps should be kept to the necessary minimum, and lymph vessels in the vicinity of the kidney hilus carefully ligatured. Therapy of a lymphocele after renal transplantation should commence with minimally invasive measures and continue with invasive procedures only if these are unsuccessful, namely, puncture and drainage then sclerotization, and then laparoscopic or open marsupialization.
Bio chemistry
University of Texas Medical Branch, USADepartment of Criminal Justice
Liberty University, USADepartment of Psychiatry
University of Kentucky, USADepartment of Medicine
Gally International Biomedical Research & Consulting LLC, USADepartment of Urbanisation and Agricultural
Montreal university, USAOral & Maxillofacial Pathology
New York University, USAGastroenterology and Hepatology
University of Alabama, UKDepartment of Medicine
Universities of Bradford, UKOncology
Circulogene Theranostics, EnglandRadiation Chemistry
National University of Mexico, USAAnalytical Chemistry
Wentworth Institute of Technology, USAMinimally Invasive Surgery
Mercer University school of Medicine, USAPediatric Dentistry
University of Athens , GreeceThe annual scholar awards from Lupine Publishers honor a selected number Read More...